NeuroPace (NPCE) Other Non-Current Liabilities (2020 - 2021)
NeuroPace (NPCE) posted quarterly Other Non-Current Liabilities of $248000.0 for Q3 2021, little changed quarter-over-quarter from $248000.0 in Q2 2021.
NeuroPace (NPCE) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends
NeuroPace's Other Non-Current Liabilities history runs 2 years deep, the most recent figure standing at $248000.0 for Q3 2021.
- In Q3 2021, Other Non-Current Liabilities changed N/A year-over-year to $248000.0; the TTM figure through Sep 2021 stood at $248000.0 (changed N/A YoY), while the FY2020 annual figure was $369000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q3 2021 stood at $248000.0, roughly flat from $248000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $369000.0 in Q4 2020, with the low at $248000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 248,000.00 |
| Jun 30, 2021 | 248,000.00 |
| Mar 31, 2021 | 274,000.00 |
| Dec 31, 2020 | 369,000.00 |